These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 7517275)

  • 21. [Evaluation of clinical usefulness of direct drug injections for increasing local circulation, into cavernous bodies of the penis for treatment of erection impotence in patients with diabetes mellitus].
    Dembe K; Jasik M; Piechna K
    Pol Tyg Lek; 1994 Jan 3-17; 49(1-3):19-20. PubMed ID: 8008670
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intracavernous injections for erectile dysfunction in patients with cardiovascular diseases and failure or contraindications for sildenafil citrate.
    Israilov S; Niv E; Livne PM; Shmueli J; Engelstein D; Segenreich E; Baniel J
    Int J Impot Res; 2002 Feb; 14(1):38-43. PubMed ID: 11896476
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Effectiveness and safety of cavernous body auto-injection therapy with papaverine/phentolamine. Study group].
    Thon WF; Hartmann U
    Urologe A; 1993 Nov; 32(6):466-9. PubMed ID: 8284856
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oral phentolamine: an alpha-1, alpha-2 adrenergic antagonist for the treatment of erectile dysfunction.
    Goldstein I
    Int J Impot Res; 2000 Mar; 12 Suppl 1():S75-80. PubMed ID: 10845768
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intracavernous injection of papaverine, phentolamine and phenoxybenzamine.
    Pettirossi O; Serenelli G
    Acta Urol Belg; 1988; 56(2):211-9. PubMed ID: 3400527
    [No Abstract]   [Full Text] [Related]  

  • 26. Oral phentolamine as treatment for erectile dysfunction.
    Becker AJ; Stief CG; Machtens S; Schultheiss D; Hartmann U; Truss MC; Jonas U
    J Urol; 1998 Apr; 159(4):1214-6. PubMed ID: 9507837
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intracavernous self-injection with phentolamine and papaverine for the treatment of impotence.
    Gasser TC; Roach RM; Larsen EH; Madsen PO; Bruskewitz RC
    J Urol; 1987 Apr; 137(4):678-80. PubMed ID: 3550149
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fibrosis of tunica albuginea: complication of long-term intracavernous pharmacological self-injection.
    Hu KN; Burks C; Christy WC
    J Urol; 1987 Aug; 138(2):404-5. PubMed ID: 2439714
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Diagnosis of erectile impotence].
    Keuler F; Altwein JE
    Urologe A; 1989 Sep; 28(5):241-7. PubMed ID: 2683318
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Physiology of erection and pharmacological management of impotence.
    Lue TF; Tanagho EA
    J Urol; 1987 May; 137(5):829-36. PubMed ID: 3553617
    [No Abstract]   [Full Text] [Related]  

  • 31. Physicochemical stability of papaverine hydrochloride-phentolamine mesylate mixtures used for intracavernous injection: a preliminary evaluation.
    Hadzija BW; Mattocks AM; Stahl GM
    J Urol; 1988 Jul; 140(1):64-5. PubMed ID: 2454330
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intracavernosal injection therapy for impotence: preliminary results.
    Gilling PJ; Wright WL; Gray JM
    N Z Med J; 1988 Jun; 101(848):423-4. PubMed ID: 3393333
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intracavernous self-injection pharmacotherapy program: analysis of results and complications.
    Valdevenito R; Melman A
    Int J Impot Res; 1994 Jun; 6(2):81-91. PubMed ID: 7951702
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Intracavernous auto-injection therapy with papaverine phentolamine via an auto-injection pen for patients with an erectile dysfunction: similar results achieved in family practice and urology].
    de Boer BJ; Lycklama a Nijeholt AA; Kleinjans HA
    Ned Tijdschr Geneeskd; 2001 Apr; 145(16):783-7. PubMed ID: 11346917
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Corpus cavernosum autoinjection therapy: initial experiences in erectile dysfunction].
    Stief CG; Bähren W; Gall H; Scherb W; Gallwitz A; Altwein JE
    Urologe A; 1986 Jan; 25(1):63-6. PubMed ID: 2421473
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Determinants of satisfactory rigidity after intracavernosal injection with prostaglandin E1 in men with erectile failure.
    Purvis K; Brekke I; Christiansen E
    Int J Impot Res; 1996 Mar; 8(1):9-16. PubMed ID: 8735188
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Erectile responses to intracavernous papaverine and phentolamine: comparison of single and combined delivery.
    Stief CG; Wetterauer U
    J Urol; 1988 Dec; 140(6):1415-6. PubMed ID: 3193506
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Response to intracavernous administration of 3 different drugs in the same group of patients with erectile dysfunction].
    Ribé N; Rajmil O; Bassas L; Jurado C; Pomerol JM
    Arch Esp Urol; 2001 May; 54(4):355-9. PubMed ID: 11455770
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intracavernous injections for impotence.
    Med Lett Drugs Ther; 1987 Oct; 29(751):95-6. PubMed ID: 3670212
    [No Abstract]   [Full Text] [Related]  

  • 40. [Experience with chemical prosthesis in impotence: report of 138 cases].
    Wang ZR
    Zhonghua Wai Ke Za Zhi; 1988 Apr; 26(4):203-5, 253. PubMed ID: 2461844
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.